Indeed, similar LBH589-responsiveness, growth arrest, and differentiation phenotypes in the P53-null Saos-2 and MG-63 human osteosarcoma cells (Supplementary Figure  1) strongly suggest that at least at low-dose LBH589 acts through P53-independent mechanisms. This evidence concerns the gene TP53 and osteosarcoma.